Dear Lauren answers with numbers, then refuses to patent the thing doing the work

Ask ten Korean brands why the cream works and nine describe a feeling. Dear Lauren hands over a trial number: +191.94% barrier recovery against untreated skin, 22 subjects, IRB-supervised, with transepidermal water loss down 20.84%. Irritation index 0.000 — recorded twice, once on a standard patch test and again on sting-reactive skin.

Then it does something stranger. The delivery system carrying those actives — a 200 nm capsule — is deliberately unpatented. The brand's stated reason: a patent means publishing it.

Take that seriously in both directions

It is a defensible choice for a small brand with one real asset, and it is a disclosure gap. An unpublished system cannot be independently verified, which means the trial results are checkable and the mechanism behind them is not. Any buyer should read the trial documents and treat the delivery story as the brand's word.

What is not in doubt is the vitamin E. Most labels list tocopheryl acetate because pure α-tocopherol degrades; Dear Lauren's RealE line runs the active form at 99.8% purity, registered in Korea as a dual-function cosmetic for both brightening and anti-wrinkle.

The cream is the barrier product — 59% centella asiatica leaf water, fragrance-free, pH 5.5 — and it carries the strongest data in the line.

Our call

Carry it if a claim on your listing has to survive a compliance review. This is the rare Korean supplier whose marketing language you can publish nearly as written, and the fragrance-free, child-safe formulation opens pharmacy and paediatric channels that scented K-beauty cannot enter.

Skip it if your customers buy K-beauty for the ritual. This line is austere on purpose — no fragrance, no sensory theatre — and next to a shelf of brands trying much harder to charm, it will look like it is not trying at all.